Table 1

Baseline clinical variables, treatment modalities and univariate analysis for predictors of good outcome (mRS ≤2) at 90 days

VariableN (%)Median (IQR)mRS ≤2*
ORp Value95% CI
Age (years)66 (29–93)0.970.0410.94 to 0.99
NIHSS score17 (4–36)0.780.0000.70 to 0.88
Baseline ASPECT score9 (4–10)1.500.0081.11 to 2.04
Time to procedure (h)*4.45 (1.16–34.3)0.990.1130.99 to 1.00
Treatment time (min)†70 (15–289)0.990.0470.980 to 0.99
Men61 (54.4)1.630.2150.75 to 3.5
Left MCA54 (54)0.790.0560.34 to 1.79
HTN81 (72.3)0.880.7660.37 to 2.04
DM22 (19.8)0.430.1240.153 to 1.252
Afib40 (36)0.880.770.39 to 1.88
Smoking16 (17)1.410.530.46 to 4.32
CAD29 (26.8)110.47 to 2.47
TICI ≥2b97 (86.6)2.070.0101.18 to 3.62
Intubation13 (12.4)0.450.20.13 to 1.59
Intravenous tPA46 (41)1.60.200.75 to 3.63
M170 (62)1.20.530.57 to 2.89
M29 (8)1.180.80.27 to 5.00
ICA terminus21 (18.7)0.810.690.29 to 2.23
Tandem21 (18.7)2.080.160.73 to 5.88
Any ICA38 (33.9)
Basilar12 (10.7)
Number of passes2 (1–8)0.880.350.68 to 1.14
Intra-arterial tPA3 (2.6)
Stent retriever32 (28.5)
Merci6 (5.3)
Intra-arterial tPA3 (2.6)
Multiple devices5 (4.4)
Hemorrhagic transformation31 (27)
Parenchymal hematoma11 (9.8)
Symptomatic bleed7 (6.2)
ENT4 (3.5)
mRS ≤2 at 90 days52 (46.1)
mRS 635 (31)
Pure MAT66 (59)1.140.730.522 to 2.50
Aspiration catheter
0.4/0.5/0.6
0.750.450.36 to 1.55
Aspiration catheter brandNavien (84)1.20.460.73 to 1.97
DAC (4)
Penumbra (23)
  • *Time to procedure: from onset of symptoms or last seen normal to groin puncture.

  • †Treatment time: from puncture to recanalization.

  • ASPECT, Alberta Stroke Program Early CT score; CAD, coronary artery disease; DM, diabetes mellitus; ENT, embolization to a new territory; HTN, hypertension; IA, intra-arterial; ICA, internal carotid artery; MAT, manual aspiration thrombectomy; MCA, middle cerebral artery; mRS, modified Rankin Scale; NIHSS, NIH Stroke Scale; TICI, Thrombolysis in Cerebral Infarction.